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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITORA Novel Approach to Neonatal Management
of Tetralogy of Fallot, With Pulmonary Atresia,
and Multiple Aortopulmonary CollateralsTetralogy of Fallot (TOF), pulmonary atresia (PA), and
multiple aortopulmonary collateral arteries (MAPCAs)
need complex interventions, and pre-natal diagnosis
allows for appropriate peri-partum planning (1).
Traditionally the post-natal echocardiogram is fol-
lowed by cardiac catheterization to identify the
MAPCA anatomy (2). We found that computedFIGURE 1 Example of Pre-Interventional Planning Using 3D Printed
Transthoracic echocardiogram (A) conﬁrms tetralogy of Fallot/pulmonar
diagnosis. Three-dimensional (3D) reconstruction (B and C) illustrates sp
arteries (blue), aorta (red), and MAPCAs (green and yellow) for central a
printing (D) provides absolute scaling for planning purposes, as well as p
shunt and prior to placement of MAPCA embolization coils.tomography (CT) imaging coupled with 3-dimensional
(3D) printing may allow better visualization of anat-
omy and improve planning. TOF with PA was pre-
natally diagnosed (Figure 1A). Cardiac CT scanning
with a minimal radiation protocol at 1 day of age
revealed dual pulmonary blood supply (Figures 1B
and 1C). The true pulmonary arteries were hypoplas-
tic and conﬂuent and appeared distributed to all
major lung segments. Three-dimensional CT recon-
struction and 3D printing (Figure 1D) were performed
to illustrate the anatomic location of the aorto-
pulmonary collaterals. The imaging and 3D print
(available in the operative suite) were used to guide
successful placement of a large central aortopulmo-
nary shunt and used as a map for subsequent coilingModels
y atresia/multiple aortopulmonary collateral arteries (MAPCAs)
atial relationship of patient-speciﬁc geometry such as true pulmonary
ortopulmonary shunt placement and coil planning. Three-dimensional
atient/family education. Angiography (E and F) captured after central
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104of redundant collateral vessels. No pre-operative
cardiac catheterization was performed. The 3D
print model was available in the cardiac catheteri-
zation laboratory during percutaneous coiling of 2 of
3 known aortopulmonary collaterals. The third was
found to be atretic as shown in Figures 1E and 1F.
This process helped focus catheter-based interven-
tion and reduced the amount of ﬂuoroscopy time
and contrast exposure. The central shunt remains in
place to promote growth of conﬂuent native pul-
monary arteries. The patient is awaiting complete
repair. Historically, CT angiography has been used
infrequently because it does not measure hemody-
namics or provide images with high enough re-
solution to allow for pre-operative planning (3).
However, as seen in Figure 1, 3D printing of CT
datasets may provide signiﬁcant advantages in
pre-operative and pre-procedural planning. This
method can allow for reductions in general anes-
thesia exposure, ﬂuoroscopy time, and cardiopulmo-
nary by pass time. Three-dimensional prints can also
be used as didactic tools to help educate parents and
patients about patient-speciﬁc cardiac anatomy and
educate trainees about speciﬁc cardiac anomalies.
Integration of this rapidly developing technology
within cardiovascular centers needs further study but
has the potential to revolutionize diagnosis and
therapy.Justin R. Ryan, MS
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579–86.Mechanical Dispersion by Strain
Echocardiography: A Predictor of
Ventricular Arrhythmias in Subjects With
Lamin A/C MutationsSudden death is the ﬁrst symptom of heart disease
in many patients. Prevention of sudden death
must therefore be achieved by screening groups of
high-risk individuals and offering an implantable
cardioverter-deﬁbrillator (ICD) as the primary pre-
vention therapy in selected individuals. Selecting
patients for primary ICD therapy remains chal-
lenging. Patients with mutations in the lamin A/C
gene (LMNA) constitute a small but important part
(5% to 8%) of those with familial dilated cardiomy-
opathy. The cardiac phenotype is malignant and
characterized by atrioventricular block, as well
as supraventricular and ventricular arrhythmias,
which often precede cardiac dilation (1). General ICD
guidelines for dilated cardiomyopathy patients, rec-
ommending primary prevention ICD at ejection
fraction (EF) <30% to 35%, are not appropriate in
patients with LMNA mutations, and we have recently
reported on risk predictors in this population (1).
Dispersed myocardial contraction by strain echocar-
diography, mechanical dispersion, is an excellent
marker of ventricular arrhythmias and is indepen-
dent of EF (2,3). We hypothesized that mechanical
dispersion by strain echocardiography may be a
marker of ventricular arrhythmias beyond EF in pa-
tients with LMNA mutations and therefore serve as a
risk marker of ventricular arrhythmias before EF
decrease.
We included 33 LMNA mutation-positive subjects
(35  16 years), of which 13 (39%) were probands and
20 (61%) were mutation-positive family members. At
presentation, 9 (27%) fulﬁlled criteria of dilated car-
diomyopathy whereas 24 (73%) had normal or mildly
dilated cardiac dimensions. Ventricular arrhythmias
were deﬁned as nonsustained (ns) ventricular tachy-
cardia (VT) if $3 consecutive ventricular beats $120
beats/min lasting <30 s (n ¼ 6). Sustained VT was
deﬁned as VT lasting >30 s, VT with hemodynamic
deterioration or ventricular ﬁbrillation (VF) (n ¼ 5).
No VT were detected in 22 subjects. All subjects gave
written informed consent in this institutional review
board–approved study.
By speckle tracking echocardiography, peak longi-
tudinal negative strain was assessed in 16 left
ventricular segments and averaged to global longi-
tudinal strain (GLS). Time intervals from start Q/R on
electrocardiogram to peak negative strain during the
